HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.

AuthorsMauro Zaccarelli, Daniela Zinzi, Maria Paola Trotta, Giuseppina Liuzzi, Pietro Sette, Patrizia Marconi, Rosa Acinapura, Andrea Antinori
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 39 Issue 1 Pg. 125-6 (May 01 2005) ISSN: 1525-4135 [Print] United States
PMID15851923 (Publication Type: Letter)
Chemical References
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate
Topics
  • Atazanavir Sulfate
  • HIV Seropositivity (drug therapy)
  • HIV-Associated Lipodystrophy Syndrome (epidemiology)
  • Humans
  • Oligopeptides (adverse effects, therapeutic use)
  • Pyridines (adverse effects, therapeutic use)
  • Switzerland (epidemiology)
  • Treatment Failure
  • Treatment Refusal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: